Business Wire01.10.18
To augment its growing focus on infection prevention solutions, Medline has announced a new distribution partnership with BioDerm Inc. to provide customers with its line of alternative urinary management devices. Catheter-associated urinary tract infections (CAUTIs) are the fourth most common healthcare associated infection, and utilizing alternatives to Foley catheters is the best way to help avoid a CAUTI.
Starting Jan. 1, Medline has had exclusive distribution rights in the United States and Canada to Men’s Liberty Acute, a male external catheter designed especially for the acute care market as a means of avoiding Foley catheter use by men within the appropriate patient diagnosis segment. Additionally, the company is distributing BioDerm’s portfolio of urinary management devices, such as the Men’s Liberty male external catheter for homecare and managed care, CathGrip family of universal securement options, FreeDerm Adhesive Remover, BioPlus+ Prep Wipe and KindKlamp Penile Clamp.
“BioDerm offers an alternative to indwelling Foley catheters to help minimize risk of infection to patients. Their products are a perfect fit in our ERASE CAUTI Comprehensive Care Solution to ensure customers have high quality tools for managing a patient’s bladder condition across all diagnoses,” said Sarah Dickinson, president of Medline’s Urology division.
Medline has collaborated with clinical leaders in hospitals nationwide to develop an effective and easy-to-adopt process that combines clinical thinking with product and educational resources to drive CAUTI prevention goals. Men’s Liberty Acute will work alongside the Medline bladder scanner to strengthen the Bladder Bundle of ERASE CAUTI and provide staff with a better alternative for managing a patient’s specific bladder condition.
“We couldn’t be happier with Medline, a leader in urology products and solutions that reduce infection rates due to catheterization, as our partner. Thanks to Medline’s sales force, the Men’s Liberty Acute product (as well as our other urology, securement and skin protection solutions) will now be more accessible to patients, thereby reducing the prevalence and associated risks of UTIs and improving their quality of life,” said Gaet Tyranski, president of BioDerm.
Medline is a global manufacturer and distributor serving the healthcare industry with medical supplies and clinical solutions. Headquartered in Northfield, Ill., the company offers more than 350,000 medical devices and support services through more than 1,400 direct sales representatives who are dedicated points of contact for customers across the continuum of care.
BioDerm Inc. is a manufacturer of proprietary hydrocolloid products for urinary management, securement, infection control and skin protection. Based in Largo, Fla., a predominance of BioDerm’s products are manufactured locally. The company challenges accepted inferior standards of care by creating products that reduce infection rates, add comfort and reliability, and improve quality of life. BioDerm’s products are sold in over 20 countries worldwide.
Starting Jan. 1, Medline has had exclusive distribution rights in the United States and Canada to Men’s Liberty Acute, a male external catheter designed especially for the acute care market as a means of avoiding Foley catheter use by men within the appropriate patient diagnosis segment. Additionally, the company is distributing BioDerm’s portfolio of urinary management devices, such as the Men’s Liberty male external catheter for homecare and managed care, CathGrip family of universal securement options, FreeDerm Adhesive Remover, BioPlus+ Prep Wipe and KindKlamp Penile Clamp.
“BioDerm offers an alternative to indwelling Foley catheters to help minimize risk of infection to patients. Their products are a perfect fit in our ERASE CAUTI Comprehensive Care Solution to ensure customers have high quality tools for managing a patient’s bladder condition across all diagnoses,” said Sarah Dickinson, president of Medline’s Urology division.
Medline has collaborated with clinical leaders in hospitals nationwide to develop an effective and easy-to-adopt process that combines clinical thinking with product and educational resources to drive CAUTI prevention goals. Men’s Liberty Acute will work alongside the Medline bladder scanner to strengthen the Bladder Bundle of ERASE CAUTI and provide staff with a better alternative for managing a patient’s specific bladder condition.
“We couldn’t be happier with Medline, a leader in urology products and solutions that reduce infection rates due to catheterization, as our partner. Thanks to Medline’s sales force, the Men’s Liberty Acute product (as well as our other urology, securement and skin protection solutions) will now be more accessible to patients, thereby reducing the prevalence and associated risks of UTIs and improving their quality of life,” said Gaet Tyranski, president of BioDerm.
Medline is a global manufacturer and distributor serving the healthcare industry with medical supplies and clinical solutions. Headquartered in Northfield, Ill., the company offers more than 350,000 medical devices and support services through more than 1,400 direct sales representatives who are dedicated points of contact for customers across the continuum of care.
BioDerm Inc. is a manufacturer of proprietary hydrocolloid products for urinary management, securement, infection control and skin protection. Based in Largo, Fla., a predominance of BioDerm’s products are manufactured locally. The company challenges accepted inferior standards of care by creating products that reduce infection rates, add comfort and reliability, and improve quality of life. BioDerm’s products are sold in over 20 countries worldwide.